Lenexa Medical

Lenexa Medical is an Australian MedTech company dedicated to personalized and precision-based pressure injury prevention and patient monitoring. Founded by graduates of the Stanford BioDesign Innovation course at the University of Melbourne, the company addresses the global challenge of pressure injuries, which significantly impact healthcare systems. The flagship product, LenexaCARE®, features an ultra-thin fabric bed sheet embedded with sensing technology and smart software. This system continuously monitors patient position and posture in real time, providing clinicians with objective data to guide care decisions. LenexaCARE® alerts caregivers when repositioning is necessary, helping to prevent pressure injuries and reduce staff workload. The technology has shown a 100% success rate in ongoing trials across various hospitals and aged care facilities in Australia and is approved for use in the US, UK, and Europe. Lenexa Medical aims to empower healthcare providers with innovative technologies that enhance care quality and patient outcomes while alleviating the financial burden of pressure injuries. The company collaborates with hospitals and aged care facilities globally, with active trials and commercial agreements in multiple regions.

• Employees 39
• Founded 2017
• Total Funding $10000000